1630074-14-4

1630074-14-4 structure

Name: Denintuzumab
Chemical Name: Denintuzumab
CAS Number: 1630074-14-4
Molecular Formula:
Molecular Weight:
Catalog: Research Areas Others
Create Date: 2023-01-17 20:18:39
Modify Date: 2025-08-25 07:40:34
Denintuzumab (hBU 12) is a recombinant humanized anti-CD19 monoclonal antibody. Denintuzumab can be used as the antibody moiety (ADC Antibody) of antibody-drug conjugates to synthesize ADC, Denintuzumab Mafodotin (SGN-CD19A). Denintuzumab Mafodotin can be used in the research of acute lymphoblastic leukemia[1].

Name	Denintuzumab

Description	Denintuzumab (hBU 12) is a recombinant humanized anti-CD19 monoclonal antibody. Denintuzumab can be used as the antibody moiety (ADC Antibody) of antibody-drug conjugates to synthesize ADC, Denintuzumab Mafodotin (SGN-CD19A). Denintuzumab Mafodotin can be used in the research of acute lymphoblastic leukemia[1].
Related Catalog	Research Areas >> Others
Target	CD19[1].
References	[1]. Farhadfar N, et al. New monoclonal antibodies for the treatment of acute lymphoblastic leukemia. Leuk Res. 2016 Oct;49:13-21.

No Any Chemical & Physical Properties